extended-field IMRT, cervical, endometrial cancer, duodenal toxicity, Pittsburgh

Women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity, according to a new study. Findings were published in the July-August 2015 issue of Practical Radiation Oncology (PRO), the American Society for Radiation Oncology’s (ASTRO’s) journal focused on the clinical practice of radiation oncology.

Lexmark  announced that it has received 510(k) Class II clearance from the U.S. Food and Drug Administration (FDA) for Lexmark NilRead, a Web-based, zero-footprint enterprise diagnostic viewer. The NilRead viewer is available in multiple configurations – core, clinical and interpretation – covering different workflows, ranging from the distribution of imaging studies and reports within the enterprise to full primary interpretation workflows in decoupled enterprise image management implementations.

Carestream is expanding into new imaging modalities — cone beam computed tomography (CBCT) and ultrasound — and key advances in these areas will be demonstrated at the Association for Medical Imaging Management (AHRA) conference July 19-22. For cone beam CT, which is currently undergoing patient studies, a conceptual scale model will be on display.

Carestream Touch Prime XE

Civco Medical Solutions will showcase new patient positioning and immobilization innovations to attendees of the American Association of Physicists in Medicine (AAPM) annual meeting July 12 – 16 in Anaheim, California.

Body Pro-Lok ONE SBRT Immobilization

Mercom Capital Group llc, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT)/Digital Health sector for the second quarter of 2015. The comprehensive report covers deals of all sizes across the globe.

Blue Earth Diagnostics Ltd (BED) announced it has received both U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Orphan Drug Designation (ODD) for fluciclovine (18F) in the diagnosis of glioma. Fluciclovine is an investigational positron emission tomography (PET) radiopharmaceutical based on a synthetic amino acid, which appears to be preferentially taken up in a number of cancer indications, including in prostate cancer and brain tumors.

Agfa HealthCare announced that it will launch its new mobile digital radiography (DR) system with FreeView telescopic column at AHRA 2015, the Association for Medical Imaging Management's annual meeting. FreeView technology creates better maneuverability and ease of use by offering a telescoping column for an unobstructed view while driving the mobile DR system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now